Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KX2-391 Ointment in Actinic Keratosis
NCT02838628Phase 2Completed
- Sponsor
- Almirall
- Start
- Apr 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tirbanibulin in actinic keratosis (AK), sponsored by Almirall. Started Apr 2016; status: completed.
02
Drugs
tirbanibulin
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02838628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02838628.